Matches in SemOpenAlex for { <https://semopenalex.org/work/W22426589> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W22426589 endingPage "86" @default.
- W22426589 startingPage "179" @default.
- W22426589 abstract "There have been few trials comparing the efficacy of determinations of cholesterol, fibronectin and triglycerides for diagnosis of malignant ascites. In this study we measured these in 200 ascitic fluids from 93 cirrhotic patients (Group A), 47 hepatocellular-carcinoma patients (Group B), 60 extra-hepatic tumour patients (Group C), 44 of them with malignant cells (Group Cpos) and 16 without (Group Cneg). Anova one-way and the Bonferroni test for multiple comparisons showed that fibronectin and cholesterol were significantly higher in the ascitic fluids of patients of group C than of groups A and B (mean +/- ESM) (Cholesterol in A: 27.2 +/- 2.8; in B 23.5 +/- 1.5; in C: 68.6 +/- 5.3 mg/dl. Fibronectin in A: 32.7 +/- 2.8; in B 31.3 +/- 2.6; in C 127.7 +/- 11.1 mg/l). Both were significantly higher in Group Cpos than in Group Cneg (Cholesterol in Cneg: 41.2 +/- 6.7; in Cpos: 78.6 +/- 6.2 mg/dl. Fibronectin in Cneg: 55.0 +/- 11.2; in Cpos 154 +/- 12.3 mg/dl). We found no differences between cirrhotic ascites and malignant ascites due to primary liver hepatocellular-carcinoma. No difference at all in triglycerides were detected. With the Receiver-Operating Characteristic (ROC) curve, cholesterol had the best Youden Index (57%) at a cut-off of 32 mg/dl (sensitivity 78.3%, specificity 79.3% at this level); the best Youden Index (64%) for fibronectin had a cut-off of 60 mg/dl (sensitivity 65%, specificity 89.3%). Triglycerides appeared to be a great deal less effective as a diagnostic marker, with their best Youden Index (23%) at a cut-off 32 mg/dl (sensitivity 66.7%, specificity 56.4%).(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W22426589 created "2016-06-24" @default.
- W22426589 creator A5001722887 @default.
- W22426589 creator A5002723701 @default.
- W22426589 creator A5012889248 @default.
- W22426589 creator A5015116266 @default.
- W22426589 creator A5025973558 @default.
- W22426589 creator A5053086999 @default.
- W22426589 creator A5060499653 @default.
- W22426589 creator A5068830007 @default.
- W22426589 creator A5087649435 @default.
- W22426589 date "1991-05-01" @default.
- W22426589 modified "2023-10-15" @default.
- W22426589 title "Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy." @default.
- W22426589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1661195" @default.
- W22426589 hasPublicationYear "1991" @default.
- W22426589 type Work @default.
- W22426589 sameAs 22426589 @default.
- W22426589 citedByCount "3" @default.
- W22426589 countsByYear W224265892014 @default.
- W22426589 crossrefType "journal-article" @default.
- W22426589 hasAuthorship W22426589A5001722887 @default.
- W22426589 hasAuthorship W22426589A5002723701 @default.
- W22426589 hasAuthorship W22426589A5012889248 @default.
- W22426589 hasAuthorship W22426589A5015116266 @default.
- W22426589 hasAuthorship W22426589A5025973558 @default.
- W22426589 hasAuthorship W22426589A5053086999 @default.
- W22426589 hasAuthorship W22426589A5060499653 @default.
- W22426589 hasAuthorship W22426589A5068830007 @default.
- W22426589 hasAuthorship W22426589A5087649435 @default.
- W22426589 hasConcept C126322002 @default.
- W22426589 hasConcept C134018914 @default.
- W22426589 hasConcept C185592680 @default.
- W22426589 hasConcept C189165786 @default.
- W22426589 hasConcept C2777214474 @default.
- W22426589 hasConcept C2777546739 @default.
- W22426589 hasConcept C2777785397 @default.
- W22426589 hasConcept C2778019345 @default.
- W22426589 hasConcept C2778163477 @default.
- W22426589 hasConcept C2779399171 @default.
- W22426589 hasConcept C2780496750 @default.
- W22426589 hasConcept C2780678043 @default.
- W22426589 hasConcept C55493867 @default.
- W22426589 hasConcept C71924100 @default.
- W22426589 hasConcept C86492073 @default.
- W22426589 hasConcept C90924648 @default.
- W22426589 hasConceptScore W22426589C126322002 @default.
- W22426589 hasConceptScore W22426589C134018914 @default.
- W22426589 hasConceptScore W22426589C185592680 @default.
- W22426589 hasConceptScore W22426589C189165786 @default.
- W22426589 hasConceptScore W22426589C2777214474 @default.
- W22426589 hasConceptScore W22426589C2777546739 @default.
- W22426589 hasConceptScore W22426589C2777785397 @default.
- W22426589 hasConceptScore W22426589C2778019345 @default.
- W22426589 hasConceptScore W22426589C2778163477 @default.
- W22426589 hasConceptScore W22426589C2779399171 @default.
- W22426589 hasConceptScore W22426589C2780496750 @default.
- W22426589 hasConceptScore W22426589C2780678043 @default.
- W22426589 hasConceptScore W22426589C55493867 @default.
- W22426589 hasConceptScore W22426589C71924100 @default.
- W22426589 hasConceptScore W22426589C86492073 @default.
- W22426589 hasConceptScore W22426589C90924648 @default.
- W22426589 hasIssue "4" @default.
- W22426589 hasLocation W224265891 @default.
- W22426589 hasOpenAccess W22426589 @default.
- W22426589 hasPrimaryLocation W224265891 @default.
- W22426589 hasRelatedWork W1597983707 @default.
- W22426589 hasRelatedWork W2016389058 @default.
- W22426589 hasRelatedWork W2033386314 @default.
- W22426589 hasRelatedWork W2110175482 @default.
- W22426589 hasRelatedWork W2220009103 @default.
- W22426589 hasRelatedWork W2325616278 @default.
- W22426589 hasRelatedWork W2348636038 @default.
- W22426589 hasRelatedWork W2354516214 @default.
- W22426589 hasRelatedWork W2376080733 @default.
- W22426589 hasRelatedWork W2393538571 @default.
- W22426589 hasVolume "23" @default.
- W22426589 isParatext "false" @default.
- W22426589 isRetracted "false" @default.
- W22426589 magId "22426589" @default.
- W22426589 workType "article" @default.